NewAmsterdam Pharma Company N.V. Share Price Börse Stuttgart
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18 EUR | -1.10% | +7.06% | +83.84% |
Sales 2024 * | 8.6M 9.3M 776M | Sales 2025 * | 6.3M 6.81M 568M | Capitalization | 1.65B 1.78B 149B |
---|---|---|---|---|---|
Net income 2024 * | -209M -226M -18.85B | Net income 2025 * | -139M -150M -12.54B | EV / Sales 2024 * | 191 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 262 x |
P/E ratio 2024 * |
-7.83
x | P/E ratio 2025 * |
-12.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 week | +5.88% | ||
Current month | +9.09% | ||
1 month | -8.63% | ||
3 months | -15.89% | ||
6 months | +101.12% | ||
Current year | +81.82% |
Date | Price | Change |
---|---|---|
12/24/12 | 18 | -1.10% |
11/24/11 | 18.2 | +2.25% |
10/24/10 | 17.8 | -0.56% |
07/24/07 | 17.9 | +1.70% |
06/24/06 | 17.6 | +3.53% |
Delayed Quote Börse Stuttgart, June 12, 2024 at 11:34 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock